Loading provider…
Loading provider…
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician in San Diego, CA
NPI: 1043292584Primary Employer
Sharp Cardiovascular and Thoracic Center
sharp.com
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
ID State Medical License
1982
OR State Medical License
2013
CA State Medical License
1985 - 2026
UT State Medical License
1982 - 2006
WY State Medical License
1982 - 1987

American Board of Thoracic Surgery
Thoracic and Cardiac Surgery
University of California (San Diego) Medical Center
Residency • Thoracic Surgery - Independent
1986 - 1987
Residency • Surgery
1985 - 1986
University of Utah Health
Residency • Surgery
1980 - 1985
Spencer Fox Eccles School of Medicine
medicine.utah.edu
Medical School
Until 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 2 | 33361Replacement of aortic valve through the skin and femoral artery | 23 | 23 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 21 | 25 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 19 | 20 |
| 5 | 35301Removal of blood clot and portion of artery of neck | 11 | 11 |
Successful mechanical circulatory support for noncoronary shock.
Authors: Brian Jaski, Ricardo Moreno Cabral, Walter Dembitsky
Journal: J Heart Lung Transplant
Immediate cardiac allograft failure : ECMO versus total artificial heart support
Authors: Walter Dembitsky
Publication Date: 1996-07
Lead Sponsor: Deborah Ascheim
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: BIOLOGICAL: Control Solution, BIOLOGICAL: MPC Intramyocardial injection
Lead Sponsor: Abbott Medical Devices
Collaborators: Thoratec Corporation
Intervention / Treatment: DEVICE: HeartMate II LVAS, DEVICE: HeartMate 3 LVAS